Follow
Masilamani K
Masilamani K
Faculty of Pharmacy, Bharath Institute of Higher Education and Research
Verified email at bharathuniv.ac.in
Title
Cited by
Cited by
Year
Solubility enhancement of poorly soluble drugs by solid dispersion technique–A review
V Kamalakkannan, A Puratchikody, K Masilamani, B Senthilnathan
J. Pharm. Res 3 (9), 2314-2321, 2010
752010
Development and evaluation of chitosan based polymeric nanoparticles of an antiulcer drug lansoprazole
E Nagarajana, P Shanmugasundarama, V Ravichandirana, ...
Journal of Applied Pharmaceutical Science 5 (4), 020-025, 2015
482015
Promising upshot of silver nanoparticles primed from Gracilaria crassa against bacterial pathogens
V Lavakumar, K Masilamani, V Ravichandiran, N Venkateshan, ...
Chemistry Central Journal 9, 1-8, 2015
412015
Quercetin-decorated curcumin liposome design for cancer therapy: in-vitro and in-vivo studies
V Ravichandiran, K Masilamani, B Senthilnathan, A Maheshwaran, ...
Current drug delivery 14 (8), 1053-1059, 2017
282017
Enhancement of drugs bioavailability by floating drug delivery system-A review
V Kamalakkannan, A Puratchikody, VV Prasanth, K Masilamani
International Journal of Drug Delivery 3 (4), 558, 2011
282011
Determination of ionization constant (pKa) for poorly soluble drugs by using surfactants: a novel approach
V Ravichandiran, V Devarajan, K Masilamani
Der Pharmacia Lettre 3 (4), 183-92, 2011
212011
Liposome-a versatile drug delivery system
V Ravichandiran, B Senthilnathan
Der Pharmacia Sinica, 2011
202011
Liposomal drug delivery systems—a review
A Maheswaran, P Brindha, AR Mullaicharam, K Masilamani
Int J Pharm Sci Rev Res 23 (1), 295-01, 2013
182013
Community pharmacists’ attitudes towards use of medicine in rural India–An analysis of the current situation
SC Basak, A Arunkumar, K Masilamani
Int Pharm J 16 (2), 32-35, 2002
182002
Analytical method development and validation for Candesartan Cilexetil as bulk drug and in pharmaceutical dosage forms by HPLC
V Kamalakkannan, A Puratchikody, K Masilamani, T Saraswathy
Der Pharmacia Lettre 3 (3), 286-296, 2011
142011
Effect of formulation and process variables on drug content and entrapment efficiency of aceclofenac nanosuspension
RV Masilamani K
International Research Journal of Pharmacy 3 (3), 315-318, 2012
132012
In vitro antioxidant and anticancer activity of flavonoids from Cassia tora linn. leaves against human breast carcinoma cell lines.
A Vijayalakshmi, K Masilamani, E Nagarajan, V Ravichandiran
122015
Anti-Psoriatic activity of smilax china linn. rhizome
A Vijayalakshmi, V Ravichandiran, M Velraj, S Nirmala, M Anusha, ...
IJPER 47 (1), 82-89, 2013
112013
Development and evaluation of gastroretentive formulations for moxifloxacin hydrochloride
RK Gunda, A Vijayalakshmi, K Masilamani
The Thai Journal of Pharmaceutical Sciences 44 (1), 30-39, 2020
92020
Fast dissolving tablets: A Review
V Ravichandiran, K Masilamani, SS Kumar, T Kumaragurubaran, ...
Journal of Pharmacy Research 4 (8), 2590-2592, 2011
92011
Formulation development and evaluation of Tamsulosin Hydrochloride and Dutasteride in tablet dosage form
V Ravichandiran, B Senthilnathan
Der Pharmacia Sinica, 2011
92011
Design and development of dexibuprofen loaded chitosan nanoparticles
B Senthilnathan, K Gopalasatheeskumar, A Vijayalakshmi, E Bhavya, ...
Drug Invent. Today 10, 248-252, 2018
82018
DRUG DELIVERY TO THE LUNGS
V Ravichandiran, K Masilamani, S Satheshkumar, D Joseprakash
International journal of pharmaceutical sciences review and research 10 (2 …, 2011
82011
Pulsatile drug delivery systems
MK Ravichandiran V, Suba V, Senthilnathan B, Rajachandrika K, Padmapriya S ...
Biomedical and Pharmacology journal 2 (2), 227-234, 2009
8*2009
Formulation and physico-chemical evaluation of ethylcellulose microspheres containing etodolac
SS Kumar, K Masilamani, SS Srinivas, V Ravichandiran
International Conference on Biotechnology and Pharmaceutical Sciences, 372-375, 2011
72011
The system can't perform the operation now. Try again later.
Articles 1–20